Table 1.
Clinicopathological characteristics of patients with Warthin-like MEC.
| Warthin-like MEC | |
|---|---|
| Evaluable patients, N | 29 |
| Age, years, n (%) | |
| <50 | 16 (55.2) |
| ≥50 | 13 (44.8) |
| Mean (range) | 42.3 (8–68) |
| Gender, n (%) | |
| Male | 10 (34.5) |
| Female | 19 (65.5) |
| Smoking history, n (%) | 2 (6.9) |
| Location, n (%) | |
| Parotid gland | 18 (62.1) |
| Other sites | 11 (37.9) |
| Tumor size (cm) | |
| Mean (range) | 1.9 (0.4–4) |
| Well circumscribed | 1 (3.4) |
| Cellular atypia (mild, moderate and severe) | 26,1,2 (90.7,3.4,7.9) |
| Necrosis | 3 (7.9) |
| Invasive growth | 20 (69.0) |
| Nodal status | |
| Positive | 3 (10.3) |
| Negative | 26 (89.7) |
| Stage,n (%) | |
| Ⅰ+Ⅱ | 25 (86.2) |
| Ⅲ+Ⅳ | 4 (13.8) |
| Histology Grade system (LG, IG, HG, %) | |
| AFIP | 82.8,6.9,10.3 |
| Brandwein | 20.7,13.8,65.5 |
| Modified Healy | 69.0,20.7,10.3 |
| Katabi | 48.3,41.4,10.3 |
| Treatment, n (%) | |
| Resection only | 18 (62.1) |
| Extended resection & cervical Lymph node dissection | 11 (37.9) |
| Adjuvant treatment, n (%) | |
| rRdiation | 5 (17.2) |
| I125 seed implantation | 4 (13.8) |
| Follow up | 5-128 (73.3) |
| Prognosis, n (%) | |
| Live without recurrent | 28 (96.6) |
| Recurrence, metastasis, and Death of disease | 1 (3.4) |
Note: N: number.